Pfizer Inc (NYSE:PFE), an American multinational Pharmaceutical company headquartered in New York, announced on Thursday that its board of directors has declared a USD0.38 per share fourth-quarter 2020 dividend on the company's common stock.
The dividend is payable 1 December 2020, to holders of the Common Stock of record at the close of business on 6 November 2020.
The fourth-quarter 2020 cash dividend will be the 328th consecutive quarterly dividend paid by Pfizer.
Bruker Corporation to acquire ELITechGroup for EUR870m, strengthening MDx portfolio
Perrigo announces quarterly dividend increase
Bruker expands Preclinical Imaging Portfolio with acquisition of Spectral Instruments Imaging
Fusion Antibodies announces receipt of follow-on project and provides R&D update
Alvotech reports positive results for AVT03, potential biosimilar to Prolia and Xgeva
Biosenic finalises agreement with Phebra for oral arsenic troxide development